Cholinergic regulation of fuel-induced hormone secretion and respiration of SUR1-/- mouse islets

Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E525-35. doi: 10.1152/ajpendo.00579.2005. Epub 2006 Apr 25.

Abstract

Neural and endocrine factors (i.e., Ach and GLP-1) restore defective glucose-stimulated insulin release in pancreatic islets lacking sulfonylurea type 1 receptors (SUR1(-/-)) (Doliba NM, Qin W, Vatamaniuk MZ, Li C, Zelent D, Najafi H, Buettger CW, Collins HW, Carr RD, Magnuson MA, and Matschinsky FM. Am J Physiol Endocrinol Metab 286: E834-E843, 2004). The goal of the present study was to assess fuel-induced respiration in SUR1(-/-) islets and to correlate it with changes in intracellular Ca(2+), insulin, and glucagon secretion. By use of a method based on O(2) quenching of phosphorescence, the O(2) consumption rate (OCR) of isolated islets was measured online in a perifusion system. Basal insulin release (IR) was 7-10 times higher in SUR1(-/-) compared with control (CON) islets, but the OCR was comparable. The effect of high glucose (16.7 mM) on IR and OCR was markedly reduced in SUR1(-/-) islets compared with CON. Ach (0.5 microM) in the presence of 16.7 mM glucose caused a large burst of IR in CON and SUR1(-/-) islets with minor changes in OCR in both groups of islets. In SUR1(-/-) islets, high glucose failed to inhibit glucagon secretion during stimulation with amino acids or Ach. We conclude that 1) reduced glucose responsiveness of SUR1(-/-) islets may be in part due to impaired energetics, as evidenced by significant decrease in glucose-stimulated OCR; 2) elevated intracellular Ca(2+) levels may contribute to altered insulin and glucagon secretion in SUR1(-/-) islets; and 3) The amplitudes of the changes in OCR during glucose and Ach stimulation do not correlate with IR in normal and SUR1(-/-) islets suggesting that the energy requirements for exocytosis are minor compared with other ATP-consuming reactions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / antagonists & inhibitors
  • ATP-Binding Cassette Transporters / genetics*
  • Acetylcholine / pharmacology
  • Acetylcholinesterase / genetics
  • Amino Acids / pharmacology
  • Animals
  • Calcium / metabolism
  • Cell Respiration / drug effects
  • Cell Respiration / physiology*
  • Cholinergic Fibers / physiology*
  • Gene Expression / genetics
  • Glucagon / metabolism
  • Glucose / pharmacology*
  • Glucose Transporter Type 2 / genetics
  • Glyburide / pharmacology
  • Hormones / metabolism*
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Kv1.3 Potassium Channel
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / genetics
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Multidrug Resistance-Associated Proteins / antagonists & inhibitors
  • Multidrug Resistance-Associated Proteins / genetics*
  • Oxygen Consumption / drug effects
  • Potassium Channels, Inwardly Rectifying / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Drug
  • Sulfonylurea Receptors

Substances

  • ATP-Binding Cassette Transporters
  • Abcc8 protein, mouse
  • Amino Acids
  • Glucose Transporter Type 2
  • Hormones
  • Insulin
  • Kcnab1 protein, mouse
  • Kir6.2 channel
  • Kv1.3 Potassium Channel
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits
  • Multidrug Resistance-Associated Proteins
  • Potassium Channels, Inwardly Rectifying
  • RNA, Messenger
  • Receptors, Drug
  • Slc2a2 protein, mouse
  • Sulfonylurea Receptors
  • Glucagon
  • Acetylcholinesterase
  • Glucose
  • Acetylcholine
  • Glyburide
  • Calcium